Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Rohrer

Showing results (431-440 of 483) with videos related to

Pageof 49
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 3, 2024
Novel avenues of tau researchClaire E Sexton, Gal Bitan, Kathryn R Bowles, et al.
Science Translational Medicine|February 5, 2025
Proteomic analysis reveals distinct cerebrospinal fluid signatures across genetic frontotemporal dementia subtypesAitana Sogorb-Esteve, Sophia Weiner, Joel Simrén, et al.
The Lancet. Neurology|July 15, 2026
Survival estimates and their predictors in genetic frontotemporal dementia: an international, retrospective, cohort studyArabella Bouzigues, Mario Grassi, Valentina Cantoni, et al.
Journal of Alzheimer'S Disease : JAD|November 19, 2025
Neurodevelopmental effects of genetic frontotemporal dementia mutations revealed by total intracranial volume differencesIsis So, Arabella Bouzigues, Lucy L Russell, et al.
Brain : a Journal of Neurology|October 11, 2021
A data-driven disease progression model of fluid biomarkers in genetic frontotemporal dementiaEmma L van der Ende, Esther E Bron, Jackie M Poos, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 11, 2020
Neuronal pentraxin 2: a synapse-derived CSF biomarker in genetic frontotemporal dementiaEmma L van der Ende, Meifang Xiao, Desheng Xu, et al.
Brain : a Journal of Neurology|October 23, 2021
SLITRK2, an X-linked modifier of the age at onset in C9orf72 frontotemporal lobar degenerationMathieu Barbier, Agnès Camuzat, Khalid El Hachimi, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 29, 2025
Insights into pathophysiology, biomarkers, and therapeutics in tauopathies: Proceedings of the Tau2024 Global ConferenceBess Frost, James B Rowe, Rufus O Akinyemi, et al.
Communications Medicine|December 12, 2025
Clinical recognition of frontotemporal dementia with right temporal predominance: a consensus statement from the International Working GroupHulya Ulugut, Kyan Younes, Maxime Montembeault, et al.
Brain Communications|November 17, 2025
Thalamus involvement in genetic frontotemporal dementia assessed using structural and diffusion MRI: a GENFI studySonja Soskic, Henry F J Tregidgo, Emily G Todd, et al.
Pageof 49

Showing results (431-440 of 483) with videos related to

Sort By:
Pageof 49
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 3, 2024
Novel avenues of tau researchClaire E Sexton, Gal Bitan, Kathryn R Bowles, et al.
Science Translational Medicine|February 5, 2025
Proteomic analysis reveals distinct cerebrospinal fluid signatures across genetic frontotemporal dementia subtypesAitana Sogorb-Esteve, Sophia Weiner, Joel Simrén, et al.
The Lancet. Neurology|July 15, 2026
Survival estimates and their predictors in genetic frontotemporal dementia: an international, retrospective, cohort studyArabella Bouzigues, Mario Grassi, Valentina Cantoni, et al.
Journal of Alzheimer'S Disease : JAD|November 19, 2025
Neurodevelopmental effects of genetic frontotemporal dementia mutations revealed by total intracranial volume differencesIsis So, Arabella Bouzigues, Lucy L Russell, et al.
Brain : a Journal of Neurology|October 11, 2021
A data-driven disease progression model of fluid biomarkers in genetic frontotemporal dementiaEmma L van der Ende, Esther E Bron, Jackie M Poos, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 11, 2020
Neuronal pentraxin 2: a synapse-derived CSF biomarker in genetic frontotemporal dementiaEmma L van der Ende, Meifang Xiao, Desheng Xu, et al.
Brain : a Journal of Neurology|October 23, 2021
SLITRK2, an X-linked modifier of the age at onset in C9orf72 frontotemporal lobar degenerationMathieu Barbier, Agnès Camuzat, Khalid El Hachimi, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 29, 2025
Insights into pathophysiology, biomarkers, and therapeutics in tauopathies: Proceedings of the Tau2024 Global ConferenceBess Frost, James B Rowe, Rufus O Akinyemi, et al.
Communications Medicine|December 12, 2025
Clinical recognition of frontotemporal dementia with right temporal predominance: a consensus statement from the International Working GroupHulya Ulugut, Kyan Younes, Maxime Montembeault, et al.
Brain Communications|November 17, 2025
Thalamus involvement in genetic frontotemporal dementia assessed using structural and diffusion MRI: a GENFI studySonja Soskic, Henry F J Tregidgo, Emily G Todd, et al.
Pageof 49